Literature DB >> 2579204

Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.

S R George, M Watanabe, P Seeman.   

Abstract

Although dopamine agonists can recognize two states of the D2 dopamine receptor in the anterior pituitary (D2high and D2low), we examined whether the dopamine antagonists such as [3H]spiperone could recognize these two sites with different affinities. Using up to 30 concentrations of [3H]spiperone, however, we could only detect a single population of binding sites (porcine anterior pituitary homogenates) with a dissociation constant (KD) of 130 pM. When specific [3H]spiperone binding was defined by a low concentration of (+)-butaclamol (100 nM), the apparent density was low. When defined by a high concentration of (+)-butaclamol (10 microM), nonspecific sites became detectable, thus revealing two apparent populations of sites for [3H]spiperone, only one of which was specific for dopamine. Sodium chloride reduced the KD of the single population of specific D2 sites to 64 pM. Guanine nucleotide by itself had no effect on the KD, but enhanced the density by 25%. Since the density-enhancement could be eliminated by extensive washing of membranes, and could be restored by preincubation with dopamine, the nucleotide-induced elevation of D2 density appeared to be a result of the release of tightly bound endogenous dopamine. Thus, monovalent cations and guanine nucleotides appear to have separate regulatory effects on the anterior pituitary D2 receptor that modulate antagonist-receptor interactions. Several maneuvers were used to test whether [3H]spiperone could differentiate between the two agonist-detected subpopulations of sites. Twentyfold different concentrations of [3H]spiperone (47 pM and 1000 pM) were found to label identical proportions of receptors in the D2high and D2low states as detected by the agonist 6,7-dihydroxyaminotetralin (ADTN), suggesting that spiperone labelled equal proportions of D2high and D2low sites without differential affinity for them. In addition, competition of spiperone for D2high sites selectively labelled by the agonist [3H]n-propylnorapomorphine (NPA) had a virtually identical KD for spiperone as did the total D2 receptor population as determined by direct binding studies (75 pM versus 64 pM). [3H]Spiperone also bound to a uniform population of D2low sites induced by preincubation with guanine nucleotide with identical affinity as to the total D2 population. Thus, these data do not support a "reciprocal model" for the D2 receptor (i.e., antagonist having low affinity for D2high and high affinity for D2low in a manner reciprocal to agonists).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579204     DOI: 10.1111/j.1471-4159.1985.tb08740.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

Review 1.  Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.

Authors:  G B Baker; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

2.  Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.

Authors:  P Seeman; H B Niznik; H C Guan; G Booth; C Ulpian
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Heterogeneity of D2 dopamine receptors in different brain regions.

Authors:  M N Leonard; C A Macey; P G Strange
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

4.  Dopamine D2 receptors in brain and anterior pituitary recognize agonist and antagonist actions of (-)-3-PPP.

Authors:  S R George; M Watanabe; P Seeman
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

5.  [3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.

Authors:  D Grigoriadis; P Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

6.  Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.

Authors:  S Urwyler; D Coward
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-02       Impact factor: 3.000

7.  3- and 4-O-sulfoconjugated and methylated dopamine: highly reduced binding affinity to dopamine D2 receptors in rat striatal membranes.

Authors:  E Werle; T Lenz; G Strobel; H Weicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

8.  Synthesis and evaluation in rats of homologous series of [(18)F]-labeled dopamine D 2/3 receptor agonists based on the 2-aminomethylchroman scaffold as potential PET tracers.

Authors:  Vladimir Shalgunov; Jan-Peter van Wieringen; Henk M Janssen; P Michel Fransen; Rudi A J O Dierckx; Martin C Michel; Jan Booij; Philip H Elsinga
Journal:  EJNMMI Res       Date:  2015-07-25       Impact factor: 3.138

9.  Ex Vivo Characterization of a Novel Iodine-123-Labelled Aminomethylchroman as a Potential Agonist Ligand for SPECT Imaging of Dopamine D2/3 Receptors.

Authors:  Jan-Peter van Wieringen; Kora de Bruin; Henk M Janssen; P Michel Fransen; Anton G M Janssen; Peter A van Doremalen; Martin C Michel; Philip H Elsinga; Jan Booij
Journal:  Int J Mol Imaging       Date:  2014-12-25

10.  In vivo imaging of cerebral dopamine D3 receptors in alcoholism.

Authors:  David Erritzoe; Andri Tziortzi; David Bargiela; Alessandro Colasanti; Graham E Searle; Roger N Gunn; John D Beaver; Adam Waldman; David J Nutt; Massimo Bani; Emilio Merlo-Pich; Eugenii A Rabiner; Anne Lingford-Hughes
Journal:  Neuropsychopharmacology       Date:  2014-01-28       Impact factor: 7.853

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.